About Us

Patient-inspired Solutions

Alkermes is a leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies our scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.

Track Record of Innovation

Through our proven scientific, development and manufacturing capabilities, Alkermes is uniquely positioned to be an engine of innovative treatments for major clinical conditions specifically focused on central nervous system (CNS) disorders, such as schizophrenia, addiction and depression.

The success of our approach is reflected in:

• A product portfolio which includes more than 20 products on the market;
• Five key commercial products that fulfill unique treatment needs and have long periods of exclusivity;
• A substantial and growing pipeline of product candidates in clinical development;
• Our commitment to developing new treatment options for major diseases with patient needs in mind.

All this, combined with our resources and strong global presence, position us as a leading innovator in the global pharmaceutical market, today and for the future.